Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Which are the best and worst performing stocks following the market sell-off?

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
We have run the numbers to identify the best and worst FTSE 350 performers since the market sell-off started at the beginning of February.
Financial technology business NEX (NEX) noted it would benefit from increased volatility (and US tax cuts) in a 1 February trading update. The company could see greater demand for its platforms as the financial markets become more actively traded.
Delivery firm Royal Mail (RMG) is the standout performer after it made significant progress towards a deal on pay and pensions with its staff.
Support services company Stobart’s (STOB) shares responded as former boss Andrew Tinkler snapped up £0.6m worth of shares, while a management shake-up at asset manager Investec (INVP) had a positive reception.
The worst performers also principally moved on stock-specific issues. However, the negative reaction to a downbeat third quarter update from cyber security specialist Sophos (SOPH) may have been exacerbated by weaker market sentiment.
A more cautious outlook from investors could also explain the big fall at pharmaceuticals outfit Vectura (VEC) as excitement about a possible bid from GlaxoSmithKline (GSK) evaporated.
Oil services provider Petrofac (PFC) suffered as the scope of a probe into bribery, corruption and money laundering was broadened.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.